The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 4311412)

Published in BMC Med on January 30, 2015

Authors

Peter Croft1, Douglas G Altman, Jonathan J Deeks, Kate M Dunn, Alastair D Hay, Harry Hemingway, Linda LeResche, George Peat, Pablo Perel, Steffen E Petersen, Richard D Riley, Ian Roberts, Michael Sharpe, Richard J Stevens, Danielle A Van Der Windt, Michael Von Korff, Adam Timmis

Author Affiliations

1: Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University, Keele ST5 5BG, Staffordshire, UK. p.r.croft@keele.ac.uk.

Articles citing this

What have we learned from ten years of trajectory research in low back pain? BMC Musculoskelet Disord (2016) 0.85

Impairment reduction in older dizzy people in primary care: study protocol for a cluster randomised controlled trial. Trials (2015) 0.80

Generic prognostic factors for musculoskeletal pain in primary care: a systematic review. BMJ Open (2017) 0.80

Clustering of pain and its associations with health in people aged 50 years and older: cross-sectional results from the North Staffordshire Osteoarthritis Project. BMJ Open (2015) 0.76

Looking to the future: should 'prognosis' be heard as often as 'diagnosis' in medical education? Educ Prim Care (2015) 0.75

Clinical course and prognosis of musculoskeletal pain in patients referred for physiotherapy: does pain site matter? BMC Musculoskelet Disord (2017) 0.75

Discussing prognosis with patients with osteoarthritis: a cross-sectional survey in general practice. Clin Rheumatol (2015) 0.75

A 10-year prognostic model for patients with suspected angina attending a chest pain clinic. Heart (2016) 0.75

Communicating prognostic uncertainty in potential end-of-life contexts: experiences of family members. BMC Palliat Care (2016) 0.75

Individual variation in functional brain connectivity: implications for personalized approaches to psychiatric disease. Dialogues Clin Neurosci (2016) 0.75

"Medically unexplained" symptoms and symptom disorders in primary care: prognosis-based recognition and classification. BMC Fam Pract (2017) 0.75

Articles cited by this

The benefits and harms of breast cancer screening: an independent review. Lancet (2012) 15.08

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73

Overdiagnosis in cancer. J Natl Cancer Inst (2010) 10.31

Collaborative care for patients with depression and chronic illnesses. N Engl J Med (2010) 8.92

Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet (2011) 7.90

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet (2012) 6.81

Preventing overdiagnosis: how to stop harming the healthy. BMJ (2012) 6.74

Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71

Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial. JAMA (2003) 4.52

Against diagnosis. Ann Intern Med (2008) 3.69

The inevitable application of big data to health care. JAMA (2013) 3.33

Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med (2013) 3.13

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62

Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ (2013) 2.31

Knowing for the sake of knowing: the value of prognostic information. Med Decis Making (1990) 2.27

Better management of patients with multimorbidity. BMJ (2013) 1.95

Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ (2012) 1.93

Chronic pain reconsidered. Pain (2008) 1.80

Gut feelings as a third track in general practitioners' diagnostic reasoning. J Gen Intern Med (2010) 1.78

Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ (2013) 1.71

European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson (2013) 1.60

Beyond diagnostic accuracy: the clinical utility of diagnostic tests. Clin Chem (2012) 1.49

Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med (2014) 1.20

The necessary shift from diagnostic to prognostic research. BMC Fam Pract (2007) 1.11

The diagnosis of urinary tract infections in young children (DUTY): protocol for a diagnostic and prospective observational study to derive and validate a clinical algorithm for the diagnosis of UTI in children presenting to primary care with an acute illness. BMC Infect Dis (2012) 1.08

Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice. BMJ (2011) 1.07

How does computer-aided diagnosis improve the management of acute abdominal pain? Ann R Coll Surg Engl (1992) 1.02

Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial. Trials (2012) 1.01

Revision of the International Classification of Diseases to include standardized descriptions of multiple injuries and injury severity. Bull World Health Organ (2011) 0.91

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. Br J Cancer (2010) 0.89

Target cardiovascular risk rather than cholesterol concentration. BMJ (2013) 0.89

Beyond disease burden: towards solution-oriented population health. Lancet (2013) 0.85

From diagnosis to social diagnosis. Soc Sci Med (2011) 0.84

Is type 2 diabetes a category error? Lancet (2013) 0.82

Decision making and fear in the midst of life. Lancet (2010) 0.78

Address in Medicine, ON MEDICAL PROGNOSIS: ITS METHODS, ITS EVOLUTION, ITS LIMITATIONS: Delivered at the Seventeenth International Congress of Medicine. Br Med J (1913) 0.77

Sixth Annual Mario S. Verani, MD Memorial Lecture: Cardiovascular imaging--added value or added cost? J Nucl Cardiol (2008) 0.77

Articles by these authors

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57

Increasing response rates to postal questionnaires: systematic review. BMJ (2002) 19.50

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92

Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30

CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36

Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87

Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16

Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80

Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51

Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47

Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08

Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev (2009) 10.85

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (2010) 10.21

Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ (2010) 10.14

Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet (2011) 9.31

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01

Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet (2004) 8.93

Collaborative care for patients with depression and chronic illnesses. N Engl J Med (2010) 8.92

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46

Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39

Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25

SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21

Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet (2011) 8.19

Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet (2011) 7.90

Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86

Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One (2009) 7.60

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55

Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47

Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43

Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33

What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials (2006) 7.32

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04

Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet (2011) 6.91

Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) (2008) 6.88

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet (2002) 6.61

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61

Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry (2004) 6.53

Reporting recommendations for tumor marker prognostic studies. J Clin Oncol (2005) 6.31

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10

Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care (2004) 6.09

Evidence of methodological bias in hospital standardised mortality ratios: retrospective database study of English hospitals. BMJ (2009) 6.08

Where is the evidence that animal research benefits humans? BMJ (2004) 5.99

CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA (2011) 5.93

The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ (2010) 5.70

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58

No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57

Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat (2007) 5.52

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ (2009) 5.45

Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA (2004) 5.44

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int (2003) 5.37

Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ (2005) 5.36

Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records. Stat Med (2002) 5.35

The design of simulation studies in medical statistics. Stat Med (2006) 5.30

Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J (2006) 5.19

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12

Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA (2003) 5.08

Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry (2006) 5.06

Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ (2006) 5.05

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98